1. Phytotherapeutics

Phytotherapeutics​

Helixmith is dedicated in inventing and commercializing
plant-based pharmaceuticals and nutraceutical.​

개인정보처리방침

닫기

이메일무단수집거부

닫기

Helixmith is committed to developing innovative medicines with plants that are safe for human use.

Such products have advantages over synthetic drugs for treatment of chronic and intractable diseases as they have better safety and multi-target mechanisms of action. Helixmith seeks to offer a new paradigm in conquering intractable diseases with limited current therapeutics by utilizing our advanced technologies and experiences.​

Indications and Mechanisms of Action

Development Status

Scroll

Pipeline Indication Pre-clinical Phase 1 Phase 2 Phase 3 approval and market launch
Natural
Product
PG201 Osteoarthritis LAYLA Tab.​
HX204 Inflammatory bowel disease